Overview Financials News + Filings Key Docs Charts Ownership Insiders
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Quarterly results
Auditor change
|
|
Viridian Therapeutics, Inc. (MGEN)
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 05/11/2023 |
SC 13G
| Paradigm Biocapital Advisors LP reports a 5.4% stake in Viridian Therapeutics, Inc. |
| 02/09/2023 |
SC 13G
| VANGUARD GROUP INC reports a 5.2% stake in Viridian Therapeutics Inc. |
| 02/03/2023 |
SC 13G
| BlackRock Inc. reports a 6.9% stake in MIRAGEN THERAPEUTICS, INC. |
| 05/31/2022 |
SC 13G
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals: |
| 05/19/2022 |
SC 13G
| COMMODORE CAPITAL LP reports a 5% stake in VIRIDIAN THERAPEUTICS, INC. |
| 02/14/2022 |
SC 13G
| Paradigm Biocapital Advisors LP reports a 5.6% stake in Viridian Therapeutics Inc. |
| 10/14/2021 |
SC 13G
| Venrock Healthcare Capital Partners III, L.P. reports a 10% stake in Viridian Therapeutics, Inc. |
| 09/30/2021 |
SC 13G
| Vivo Opportunity, LLC reports a 7.7% stake in Viridian Therapeutics, Inc. |
| 09/24/2021 |
SC 13G
| Deep Track Capital, LP reports a 9.9% stake in VIRIDIAN THERAPEUTICS, INC. |
| 09/10/2021 |
SC 13G
| TCG Crossover Management, LLC reports a 9.5% stake in Viridian Therapeutics, Inc. |
| 08/26/2021 |
SC 13G
| Frazier Life Sciences Public Fund, L.P. reports a 13.6% stake in Viridian Therapeutics, Inc. |
| 05/10/2021 |
SC 13G
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals: |
| 03/10/2021 |
SC 13G
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals: |
| 02/19/2021 |
SC 13G
| Hawkes Bay Master Investors L.P. reports a 7% stake in VIRIDIAN THERAPEUTICS, INC. |
| 01/19/2021 |
SC 13G
| Cormorant Asset Management, LP reports a 10% stake in Miragen Therapeutics, Inc. |
| 01/11/2021 |
SC 13G
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals: |
| 01/11/2021 |
SC 13G
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals: |
| 01/07/2021 |
SC 13G
| Ally Bridge MedAlpha Master Fund L.P. reports a 10% stake in Miragen Therapeutics, Inc. |
| 12/17/2020 |
SC 13G
| RA CAPITAL MANAGEMENT, L.P. reports a 11.6% stake in Miragen Therapeutics, Inc. |
| 11/09/2020 |
SC 13G
| BIOTECHNOLOGY VALUE FUND L P reports a 10% stake in Miragen Therapeutics, Inc. |
| 11/09/2020 |
SC 13G
| Logos Global Management LP reports a 8.8% stake in Miragen Therapeutics, Inc. |
| 10/29/2020 |
SC 13G
| Point72 Asset Management, L.P. reports a 9.5% stake in Miragen Therapeutics, Inc. |
| 01/03/2019 |
SC 13G
| 683 Capital Partners, LP reports a 5.5% stake in Miragen Therapeutics, Inc. |
| 04/03/2017 |
SC 13G
| JAFCO SV4 Investment Limited Partnership reports a 5.4% stake in Miragen Therapeutics, Inc. |
| 03/10/2017 |
SC 13G
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals |
| 02/17/2017 |
SC 13G
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals |
|
|